By Suvarna Bhatt
San Francisco, March 21 (BioSpace) – Rockville, Maryland based CytImmune Sciences, Inc., a clinical stage nano-biotechnology, announces the appointment of Mitchell S. Marder as Vice President and General Counsel of the company. CytImmune also announces the appointment of Kenneth B. Whit to the company’s Board of Directors.
Contact Suvarna Bhatt at sbhatt@biospace.com.
